{"id":3104,"date":"2015-11-26T07:30:00","date_gmt":"2015-11-26T07:30:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/xps-approved-in-canada\/"},"modified":"2015-11-26T07:30:00","modified_gmt":"2015-11-26T07:30:00","slug":"xps-approved-in-canada","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-approved-in-canada\/","title":{"rendered":"XPS\u2122 approved in Canada"},"content":{"rendered":"
XVIVO Perfusion has obtained approval for the XPS\u2122 (Xvivo Perfusion System) in Canada. This enables clinical use of the XPS\u2122 in Canada.<\/strong><\/div>\n<\/p>\n

Health Canada has approved the XPS\u2122 for clinical use in Canada. With its integrated Hamilton C2 ventilator and MAQUET CardioHelp centrifugal pump, the XPS\u2122 is the most flexible and complete platform on the market for EVLP (Ex Vivo Lung Perfusion), and it gives the transplant team full control over the entire process. The design of the XPS\u2122 means that X-rays and automatic measurements of oxygen and pH can be carried out while EVLP evaluation is ongoing. The XPS\u2122 has a user-friendly graphic interface with touchscreen functionality and data capture of the lung\u2019s values during the entire EVLP procedure. This provides the basis for analysis and evaluation before a final clinical decision. <\/span><\/p>\n<\/p>\n

XVIVO Perfusion\u2019s XPS\u2122 and STEEN Solution\u2122 are the only approved products in the USA for evaluation of marginal lungs before transplantation. The XPS\u2122 and STEEN Solution\u2122 are also CE marked in Europe and approved by the TGA for clinical use in Australia. Leading clinics in the USA and Europe have obtained good clinical results when using XPS\u2122. <\/span><\/p>\n<\/p>\n

\u201cWe are delighted that the XPS\u2122 is also now available for clinical lung transplantation in Canada, as this means that the XPS\u2122 has now been approved in all the major markets in the world,\u201d says Magnus Nilsson, CEO of XVIVO Perfusion.<\/span><\/p>\n<\/p>\n

November 26, 2015
<\/span>Gothenburg
XVIVO Perfusion AB (publ)<\/p>\n

\n

For further information please contact:
<\/span>
Christoffer Rosenblad, CFO, +1 720 616 2101, christoffer.rosenblad@xvivoperfusion.com<\/a><\/span>
For further information on XVIVO Perfusion\u2019s business, please refer to the company\u2019s website, www.xvivoperfusion.com<\/a><\/span><\/p>\n

The information was submitted for publication on\u00a0November 26 at 8:30 a.m.<\/span><\/p>\n

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.<\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

XVIVO Perfusion has obtained approval for the XPS\u2122 (Xvivo Perfusion System) in Canada. This enables clinical use of the XPS\u2122…<\/p>\n","protected":false},"template":"","class_list":["post-3104","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-en","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-regulatory-listing","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-ci-other"],"acf":[],"yoast_head":"\nXPS\u2122 approved in Canada - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-approved-in-canada\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"XPS\u2122 approved in Canada - XVIVO\" \/>\n<meta property=\"og:description\" content=\"XVIVO Perfusion has obtained approval for the XPS\u2122 (Xvivo Perfusion System) in Canada. This enables clinical use of the XPS\u2122...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-approved-in-canada\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xps-approved-in-canada\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xps-approved-in-canada\\\/\",\"name\":\"XPS\u2122 approved in Canada - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2015-11-26T07:30:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xps-approved-in-canada\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xps-approved-in-canada\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xps-approved-in-canada\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"XPS\u2122 approved in Canada\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"XPS\u2122 approved in Canada - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-approved-in-canada\/","og_locale":"en_US","og_type":"article","og_title":"XPS\u2122 approved in Canada - XVIVO","og_description":"XVIVO Perfusion has obtained approval for the XPS\u2122 (Xvivo Perfusion System) in Canada. This enables clinical use of the XPS\u2122...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-approved-in-canada\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-approved-in-canada\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-approved-in-canada\/","name":"XPS\u2122 approved in Canada - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2015-11-26T07:30:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-approved-in-canada\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-approved-in-canada\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-approved-in-canada\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"XPS\u2122 approved in Canada"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/3104","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=3104"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}